In REACTOME, cell-cell communication, glucose metabolism, regulation of PLK1 activity at the G2/M transition, metabolism of nucleotides, organization of the cell junction and platelet activation, signaling and aggregation are enriched pathways for early NSCLC. The gene discussed is PLK1; the disease is non-small cell lung carcinoma.